Solaris Vaccines

Founded to tackle global health challenges, Solaris Vaccines is a biotechnology company focused on developing therapeutic vaccines for infectious diseases. Their core mission is to create rapid, safe, and effective vaccines using innovative methods. The company's flagship technology, the SolaVAX method, employs riboflavin (vitamin B2) and UV light to inactivate pathogens swiftly and effectively. This approach aims to overcome the limitations of traditional vaccine development, such as slow production times, technical complexity, and the use of toxic chemicals.

Solaris Vaccines has garnered attention for its pioneering work in vaccine technology. Key figures in the company include leading scientists and industry experts committed to advancing global health. The company has achieved significant milestones in preclinical trials, demonstrating the efficacy and safety of their SolaVAX method. By addressing critical gaps in vaccine development, Solaris Vaccines is poised to make a substantial impact on public health worldwide.